Risperdal Male Breast Growth Lawsuit Settles as Trial Begins
Johnson & Johnson agreed to settle a Risperdal lawsuit this week, resolving a case that claimed their antipsychotic drugs can cause substantial male breast growth.
The settlement came as trial was about to begin for a lawsuit brought by 21-year-old Aaron Banks, who alleged that he grew breast due to Risperdal side effects, causing him to suffer psychological trauma and undergo surgery to have the breasts removed.
Banks’ case was the first of several dozen Risperdal male breast growth lawsuits that was scheduled to reach a jury. Some of the cases also involved use of the schizophrenia medication Invega, which contains the primary active metabolite of Risperdal.
Learn More About
Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia.Learn More About this Lawsuit See If You Qualify Now >
The complaints all involve similar allegations that Johnson & Johnson’s Janssen Pharmaceutica subsidiary failed to adequately warn about the risk of breast growth among teen boys given the antipsychotic medications.
Side effects of Risperdal and Invega increase the risk that boys may experience dramatic breast growth, according to allegations raised in the complaints. In some cases, boys grew breasts measuring as large as a 38D cup after using the medications.
Risperdal also increases the risk of significant weight gain, and in many cases doctors initially miss or dismiss signs of male breast growth, assuming it is connected to increases in weight. However, surgical breast removal or reduction may be necessary in some cases due to the unnatural growth.
While Risperdal currently carries a warning that unusual breast growth could be a side effect of the medication, the lawsuits allege that the risks were not properly emphasized and that manufacturers downplayed the severity and numbers involved. According to prescribing information packaged with the drug, 2.3% of adolescents in clinical trials experienced breast growth due to elevated levels of the hormone prolactin.
Most of the cases filed throughout the United States are pending in the Philadelphia Court of Common Pleas, which had scheduled the Banks’ lawsuit to serve as a “bellwether” trial, to help the parties gauge how juries are likely to respond to evidence and testimony that may be repeated throughout many cases. The Risperdal settlement was announced on the first day of the scheduled trial, but no details have been released about the terms of the agreement.
albertJanuary 28, 2013 at 11:12 pm
i spent 17 months in the orange county jail,orlando,fl and all the time took resperdal for my mental illness and my brest grew to the size of a peach and im verv embaressed to take my shirt off in public or in front of my wife.im thinking on a brest reduction.this is very emberessing to me.what can i do in sueing for damages.i acidently saw this law suit on tbs tv.can i get some representation.
"*" indicates required fields
More Top Stories
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.
Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states